Adaptive Biotechnologies (ADPT) Other Operating Expenses (2018 - 2026)

Adaptive Biotechnologies (ADPT) has 9 years of Other Operating Expenses data on file, last reported at $44.8 million in Q1 2026.

• Quarterly Other Operating Expenses rose 10.84% year-over-year to $44.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $172.0 million (up 4.61% YoY) and the FY2025 annual result came in at $167.6 million, up 2.37% from the prior year.
• Other Operating Expenses grew to $44.8 million in Q1 2026 per ADPT's latest filing, from $43.1 million in the prior quarter.
• The five-year high for Other Operating Expenses was $67.4 million in Q4 2023, with the low at $36.8 million in Q3 2022.
• Average Other Operating Expenses over 5 years is $42.5 million, with a median of $40.7 million recorded in 2022.
• Year-over-year, Other Operating Expenses surged 65.41% in 2023 and tumbled 40.69% in 2024.
• Adaptive Biotechnologies' Other Operating Expenses stood at $40.7 million in 2022, then jumped by 65.41% to $67.4 million in 2023, then plunged by 40.69% to $40.0 million in 2024, then climbed by 7.94% to $43.1 million in 2025, then rose by 3.93% to $44.8 million in 2026.
• Business Quant data shows ADPT's Other Operating Expenses at $44.8 million in Q1 2026, $43.1 million in Q4 2025, and $42.1 million in Q3 2025.